Treatment advantage in HBV/HIV coinfection compared to HBV monoinfection in a South African cohort
Open Access
- 1 July 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Infection
- Vol. 81 (1), 121-130
- https://doi.org/10.1016/j.jinf.2020.04.037
Abstract
No abstract availableFunding Information
- Wellcome Trust (110110/Z/15/Z)
This publication has 45 references indexed in Scilit:
- Hepatitis B and C Co-Infection among HIV-Infected Adults while on Antiretroviral Treatment: Long-Term Survival, CD4 Cell Count Recovery and Antiretroviral Toxicity in CambodiaPLOS ONE, 2014
- Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-AnalysisPLOS ONE, 2013
- Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus InfectionAnnals of Internal Medicine, 2013
- Sustainable development goals for people and planetNature, 2013
- Patterns and Causes of Suboptimal Response to Tenofovir-Based Therapy in Individuals Coinfected With HIV and Hepatitis B VirusClinical Infectious Diseases, 2013
- Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: An updated meta-analysisJournal of Hepatology, 2010
- Side effects of long-term oral antiviral therapy for hepatitis BJournal of Hepatology, 2009
- Thrombocytopenia associated with chronic liver diseaseJournal of Hepatology, 2008
- Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration RateAnnals of Internal Medicine, 2006
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionJournal of Hepatology, 2006